Document Detail


Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome.
MedLine Citation:
PMID:  21370262     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Pramipexole and ropinirole have become the first-line treatment for restless legs syndrome. The aim of this study was to perform the first direct comparison between these two molecules in restless legs syndrome. Methods: A double-blind, placebo-controlled, double-night and prospective investigation was carried out in 45 consecutive naïve patients with idiopathic restless legs syndrome. Each patient underwent two consecutive full-night polysomnographies: the first baseline recording was performed without premedication and, before the second recording, first group received a single oral dose of 0.25 mg pramipexole, second group a single oral dose of 0.5 mg ropinirole, and the remaining patients received placebo. Results and Discussion: Both dopamine agonists improved restless legs syndrome symptoms and markedly suppressed periodic leg movements during sleep compared to placebo, without significant differences between pramipexole and ropinirole. No significant side effects, except for mild morning nausea (2 patients treated with ropinirole, 3 with pramipexole, and 1 with placebo), were reported. © 2010 Movement Disorder Society.
Authors:
Mauro Manconi; Raffaele Ferri; Marco Zucconi; Alessandro Oldani; Laura Giarolli; Valentina Bottasini; Luigi Ferini-Strambi
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-2
Journal Detail:
Title:  Movement disorders : official journal of the Movement Disorder Society     Volume:  -     ISSN:  1531-8257     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8610688     Medline TA:  Mov Disord     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Movement Disorder Society.
Affiliation:
Department of Neurology, Sleep Disorders Center, Scientific Institute and University Ospedale San Raffaele, Vita-Salute University, Milan, Italy; Neurocenter (EOC) of Southern Switzerland, Ospedale Civico, Lugano, Switzerland. manconi.mauro@hsr.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A film of patients with movement disorders made in Queen Square, London in the Mid-1920s by Samuel A...
Next Document:  Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectr...